OTCMKTS:SSMXY - SYSMEX CORP/ADR Stock Price, News, & Analysis

$33.93
+0.05 (+0.15 %)
(As of 06/25/2019 01:37 PM ET)
Today's Range
$33.90
Now: $33.93
$34.00
50-Day Range
$28.1320
MA: $34.18
$35.8150
52-Week Range
$22.01
Now: $33.93
$50.08
Volume1,892 shs
Average Volume12,186 shs
Market Capitalization$14.14 billion
P/E Ratio37.70
Dividend Yield0.32%
Beta0.36
Sysmex Corporation, together with its subsidiaries, engages in the development, manufacture, sale, and export/import of diagnostic instruments, reagents, and related software for the use in hematology, urinalysis, immunochemistry, clinical chemistry, and hemostasis. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; systems for high-volume testing in labs; and hematology analyzers for animals. The company also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for to test for liver fibrosis progression and atopic dermatitis; and support services for hemostasis products. In addition, it offers systems for the detection of cancer lymph node metastasis; cytogenic testing services; and lab assay services. It serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. The company operates in the Americas, Europe, the Middle East, Africa, the Asia Pacific, China, and Japan. Sysmex Corporation has a collaboration with MolecularMD Corporation to develop and commercialize companion diagnostics; and a strategic collaboration with Biolidics Limited for the development of laboratory assays in the field of circulating tumor cells. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SSMXY
CUSIPN/A
CIKN/A
Phone817-8265-0500

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.66 billion
Cash Flow$1.1672 per share
Book Value$5.47 per share

Profitability

Net Income$373.45 million

Miscellaneous

Employees8,445
Market Cap$14.14 billion
Next Earnings Date8/2/2019 (Estimated)
OptionableNot Optionable

Receive SSMXY News and Ratings via Email

Sign-up to receive the latest news and ratings for SSMXY and its competitors with MarketBeat's FREE daily newsletter.

SYSMEX CORP/ADR (OTCMKTS:SSMXY) Frequently Asked Questions

What is SYSMEX CORP/ADR's stock symbol?

SYSMEX CORP/ADR trades on the OTCMKTS under the ticker symbol "SSMXY."

When is SYSMEX CORP/ADR's next earnings date?

SYSMEX CORP/ADR is scheduled to release their next quarterly earnings announcement on Friday, August 2nd 2019. View Earnings Estimates for SYSMEX CORP/ADR.

Has SYSMEX CORP/ADR been receiving favorable news coverage?

News stories about SSMXY stock have trended neutral this week, according to InfoTrie Sentiment Analysis. InfoTrie scores the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. SYSMEX CORP/ADR earned a media sentiment score of 0.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the stock's share price in the immediate future. View News Stories for SYSMEX CORP/ADR.

Who are some of SYSMEX CORP/ADR's key competitors?

What other stocks do shareholders of SYSMEX CORP/ADR own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SYSMEX CORP/ADR investors own include Stericycle (SRCL) and Cellular Biomedicine Group (CBMG).

Who are SYSMEX CORP/ADR's key executives?

SYSMEX CORP/ADR's management team includes the folowing people:
  • Mr. Hisashi Ietsugu, Chairman of the Managing Board, CEO & Pres
  • Mr. Yukio Nakajima, Sr. Exec. Officer, Sr. MD, CFO & Member of the Managing Board
  • Mr. Kaoru Asano, CTO, COO LS Bus. Unit, Sr. MD, Sr. Exec. Officer & Member of the Managing Board (Age 74)
  • Mr. Frank Buescher, Exec. Officer
  • Mr. Yukio Hamaguchi, Sr. Exec. Officer

How do I buy shares of SYSMEX CORP/ADR?

Shares of SSMXY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is SYSMEX CORP/ADR's stock price today?

One share of SSMXY stock can currently be purchased for approximately $33.93.

How big of a company is SYSMEX CORP/ADR?

SYSMEX CORP/ADR has a market capitalization of $14.14 billion and generates $2.66 billion in revenue each year. The company earns $373.45 million in net income (profit) each year or $0.90 on an earnings per share basis. SYSMEX CORP/ADR employs 8,445 workers across the globe.View Additional Information About SYSMEX CORP/ADR.

What is SYSMEX CORP/ADR's official website?

The official website for SYSMEX CORP/ADR is http://www.sysmex.co.jp/.

How can I contact SYSMEX CORP/ADR?

SYSMEX CORP/ADR's mailing address is 1-5-1 Wakinohama-Kaigandori Chuo-ku, Kobe M0, 651-0073. The company can be reached via phone at 817-8265-0500.


MarketBeat Community Rating for SYSMEX CORP/ADR (OTCMKTS SSMXY)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  59 (Vote Outperform)
Underperform Votes:  91 (Vote Underperform)
Total Votes:  150
MarketBeat's community ratings are surveys of what our community members think about SYSMEX CORP/ADR and other stocks. Vote "Outperform" if you believe SSMXY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SSMXY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/25/2019 by MarketBeat.com Staff

Featured Article: What is a recession?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel